title: [Questionnaire survey on patients receiving scheduled inpatient chemotherapy clarifies the issues of outpatient chemotherapy for advanced or recurrent colorectal cancer].
abstract: In recent 10 years, chemotherapy for advanced or recurrent colorectal cancer has progressed. FOLFOX and FOLFIRI regimens have been widely used for the patients with advanced colorectal cancer. Although these regimens can be administered without hospitalization via subcutaneous infusion reservoir, some patients prefer scheduled inpatient admissions for chemotherapy. In this study, we made a questionnaire survey for 11 patients receiving inpatient chemotherapy, which clarified the issues of outpatient chemotherapy for advanced and recurrent colorectal cancer.
authors.affiliation: Dept. of Oncology and Hematology, Jikei University School of Medicine.
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Arakawa
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Sakuyama
authors.forename: Tamotsu
authors.initials: T
authors.lastname: Ichiba
authors.forename: Daisuke
authors.initials: D
authors.lastname: Inoue
authors.forename: Tadashi
authors.initials: T
authors.lastname: Kobayashi
authors.forename: Keisuke
authors.initials: K
authors.lastname: Aiba
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010045:Outpatients; D012008:Recurrence; D011795:Surveys and Questionnaires
chemical_list: D000970:Antineoplastic Agents